- Home
- TNGX vs FINV Comparison
TNGX vs FINV Comparison
Compare TNGX & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | FINV |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TNGX | FINV |
|---|---|---|
| Price | $12.31 | $5.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $15.00 | $11.55 |
| AVG Volume (30 Days) | ★ 2.6M | 1.0M |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,069,000.00 | N/A |
| Revenue This Year | $52.63 | $6.02 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.87 |
| Revenue Growth | ★ 15.17 | N/A |
| 52 Week Low | $1.04 | $4.70 |
| 52 Week High | $13.60 | $10.90 |
Technical Indicators
Market Signals| Indicator | TNGX | FINV |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 47.60 |
| Support Level | $11.00 | $4.93 |
| Resistance Level | $13.53 | $5.55 |
| Average True Range (ATR) | 0.77 | 0.21 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 54.46 | 25.33 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About FINV FinVolution Group
FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.